The Unlicensed Lives of Antidepressants in India: GeneriC Drugs, Unqualified Practitioners, and Floating Prescriptions

Transcultural Psychiatry

Volumn 46, Issue 1, 2009, Pages 86-106

  Ecks, Stefan ^a   Basu, Soumita ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

depression; fluoxetine; globalization; India; prescription practices; psychopharmaceuticals

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; DAXID; FLUDAC; FLUNIL; FLUOXETINE; FLUVOXAMINE; GENERIC DRUG; OFLOXACIN; PAROXETINE; PRODEP; SERTRALINE; UNCLASSIFIED DRUG;

CONFERENCE PAPER; DEPRESSION; DRUG COST; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG MARKETING; EUROPE; HEALTH CARE ACCESS; HEALTH CARE FINANCING; HEALTH PRACTITIONER; HUMAN; INDIA; LICENCE; PATENT; POLITICAL SYSTEM; PRESCRIPTION; PRIMARY HEALTH CARE; PROFESSIONAL COMPETENCE; SOCIOECONOMICS; UNITED STATES;

ANTIDEPRESSIVE AGENTS; BRAIN; CAPITALISM; CLINICAL COMPETENCE; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; DEVELOPING COUNTRIES; DRUG APPROVAL; DRUG INDUSTRY; DRUGS, GENERIC; ETHICS, MEDICAL; FLUOXETINE; HUMANS; INDIA; LICENSURE; MEDICAL INDIGENCY; PRESCRIPTION DRUGS; SOCIAL CHANGE; SOCIAL JUSTICE; SOCIAL MARKETING;

EID: 63049112478     PISSN: 13634615     EISSN: None     Source Type: Journal    
DOI: 10.1177/1363461509102289     Document Type: Article

References (20)

1. Applbaum, K. (2006). Educating for global mental health. In A. Petryna, A. Lakoff, & A. Kleinman (Eds.), Global pharmaceuticals (pp. 85–110). Durham, NC: Duke University Press.
2. Bhugra, D., & Mastrogianni, A. (2004). Globalisation and mental disorders: Overview with relation to depression. British Journal of Psychiatry, 184, 10-20.
3. Braithwaite, J., & Drahos, P. (2000). Global business regulation. Cambridge: Cambridge University Press.
4. Chaudhuri, S. (2005). The WTO and India's pharmaceuticals industry. New Delhi, India: Oxford University Press.
5. Clarke, A.E., Shim, J.K., Mamo, L., Fosket, J.R., & Fishman, J.R. (2003). Biomedicalization: Technoscientific transformations of health, illness, and U.S. medicine. American Sociological Review, 68(2), 161-194.
6. Dr. Reddy's Limited. (2006). Annual report 2005-2006: Creating global enterprise. Retrieved, July 31, 2007, from http://www.drreddys.com/investors/annualreports.htm.
7. Ecks, S. (2008). Global pharmaceutical markets and corporate citizenship: The case of Novartis’ anti-cancer drug Glivec. BioSocieties, 3, 165-181.
8. Eli Lilly. (2007). Welcome to Prozac.com. Retrieved, July 31, 2007, from http://www.prozac.com/index.jsp.
9. Ernst & Young. (2005). Unveiling India's pharmaceutical future: Health sciences industry report. Retrieved, July 31, 2007, from http://www.ey.com/global/download.nsf/India/HS_INDIA/file/INDIA.pdf.
10. Government of India. (2003). Report of the expert committee on a comprehensive examination of drug regulatory issues, including the problem of spurious drugs. New Delhi: Ministry of Health and Family Welfare.
11. Healy, D. (1998). The antidepressant era. Cambridge, MA: Harvard University Press.
12. Healy, D. (2004). Let them eat Prozac: The unhealthy relationship between the pharmaceutical industry and depression. New York: New York University Press.
13. Jayan, T.V. (2008, March 2). That secret disease. The Telegraph (Calcutta).
14. Jeffery, R., Ecks, S., & Brhlikova, P. (2007). Global assemblages of pharmaceuticals: Rethinking TRIPS and GMP. Biblio, 30(3), 45-52.
15. Kirmayer, L., & Minas, H. (2000). The future of cultural psychiatry: An international perspective. Canadian Journal of Psychiatry, 45(5), 438-446.
16. Mao Tse-tung. (1979). In memory of Norman Bethune, Dec. 21, 1939. In Selected works of Mao Tse-tung, Vol. 2. Peking: Foreign Languages Press. Retrieved, July 31, 2007, from http://www.marxists.org/reference/archive/mao/selectedworks/volume-2/mswv2_25.htm. (Original work published 1939)
17. Pharmabiz. (2006, December 29). OPPI to adopt marketing code for medicine. Retrieved, July 31, 2007, from http://www.pharmabiz.com/article/detnews.asp?articleid=36892§ionid=43.
18. Rose, N. (2006). Disorders without borders? The expanding scope of psychiatric practice. BioSocieties, 1, 465-484.
19. Tripathi, S.K., Dey, D., & Hazra, A. (2005). Medicine prices and affordability in the state of West Bengal, India: Report of a survey supported by World Health Organization and Health Action International. Retrieved, July 31, 2007, from http://www.haiweb.org/medicineprices/surveys/200412IW/survey_report.pdf.
20. World Health Organization. (WHO). (2001). Mental health: New understanding, new hope: The world health report 2001. Geneva: World Health Organization.